Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.47 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.47 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | CDK4 | P11802 | 1/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.46 |
| ▸ | CCND1 | P24385 | 1/20 | 0.46 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30503124 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL17281453 | 0.81 | RAB9A (0.72) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL20669009 | 0.79 | RAB9A (0.70) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL18133621 | 0.79 | RAB9A (0.70) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL15001036 | 0.79 | RAB9A (0.57) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL23607006 | 0.78 | ALDH1A1 (0.46) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL20673464 | 0.78 | MAPT (0.44) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL16153614 | 0.78 | RAB9A (0.54) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL6483920 | 0.77 | ALDH1A1 (0.44) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL7905037 | 0.77 | CYP3A4 (0.41) | ALDH1A1MAPTHPGDRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11829036-B2 | Optically anisotropic multilayer product and method for producing same | ZEON CORPORATION (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | CHANGCHUN HYPERIONS TECH CO LTD (CN) | 2023-01-26 | — | — | US | disclosed |
| US-20220209132-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-06-30 | — | — | US | disclosed |
| EP-3674757-B1 | POLYMERIZABLE LIQUID CRYSTAL MATERIAL, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICAL ANISOTROPIC BODY, POLARIZER, ANTIREFLECTIVE FILM, DISPLAY DEVICE AND METHOD FOR MANUFACTURING POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | ZEON CORP (JP) | 2022-04-20 | — | — | EP | disclosed |
| US-20210214614-A1 | LIQUID CRYSTAL CURED LAYER, PRODUCTION METHOD THEREFOR, OPTICAL FILM, POLARIZING PLATE, AND DISPLAY DEVICE | ZEON CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| WO-2021131856-A1 | LIQUID CRYSTALLINE COMPOUND PRODUCTION METHOD | 日本ゼオン株式会社 | 2021-07-01 | — | — | WO | disclosed |
| WO-2020137529-A1 | RETARDATION FILM, METHOD FOR PRODUCING SAME AND POLARIZING PLATE | 日本ゼオン株式会社 | 2020-07-02 | — | — | WO | disclosed |
| EP-3674757-A1 | POLYMERIZABLE LIQUID CRYSTAL MATERIAL, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICAL ANISOTROPIC BODY, POLARIZER, ANTIREFLECTIVE FILM, DISPLAY DEVICE AND METHOD FOR MANUFACTURING POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | Zeon Corporation (JP) | 2020-07-01 | — | — | EP | disclosed |
| US-10647662-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2020-05-12 | — | — | US | disclosed |
| WO-2020045094-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL CURED FILM, POLARIZATION PLATE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL CURED FILM PRODUCTION METHOD | 日本ゼオン株式会社 | 2020-03-05 | — | — | WO | disclosed |
| WO-2002060374-A2 | BENZ-1,3-AZOLE DERIVATIVES AND THEIR USES AS HEPARANASE INHIBITORS | INSIGHT STRATEGY AND MARKETING LTD (IL) | 2002-08-08 | — | — | WO | disclosed |
| EP-1223197-A2 | Symmetric, monofunctionalised polymethine dyes labelling reagents | Innosense S.r.l. (IT) | 2002-07-17 | — | — | EP | disclosed |
| EP-1221465-A1 | Symmetric, monofunctionalised polymethine dyes labelling reagents | Innosense S.r.l. (IT) | 2002-07-10 | — | — | EP | disclosed |
| EP-0565121-B1 | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO LTD (JP) | 1999-07-14 | — | — | EP | disclosed |
| EP-0772607-A1 | WATER-SOLUBLE METHINE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1997-05-14 | — | — | EP | disclosed |
| US-5599825-A | ANTITUMOR AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1997-02-04 | — | — | US | disclosed |
| US-5559240-A | METHINE AND THIAZOLE DYES; STORAGE STABILITY; DISCOLORATION INHIBITION | FUJI PHOTO FILM CO., LTD. (JP) | 1996-09-24 | — | — | US | disclosed |
| WO-1996003393-A1 | WATER-SOLUBLE METHINE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1996-02-08 | — | — | WO | disclosed |
| US-5397693-A | Methine dyes | FUJI PHOTO FILM CO., LTD. (JP) | 1995-03-14 | — | — | US | disclosed |
| EP-0565121-A1 | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1993-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647662-B2 | Polymerizable compound and optically anisotropic body | RCC1, SMC4, SMCHD1 | ALDH1A1 4138/4885MAPT 43/4885HPGD 4355/4885 |
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | TRDMT1, TCF4, TRMT1 | ALDH1A1 1764/4885MAPT 647/4885HPGD 4726/4885 |
| US-20220209132-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | EML4, STOM, GJB2 | ALDH1A1 2548/4885MAPT 553/4885HPGD 2011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.